Agilent Technologies Inc.

Agilent Technologies Inc., Customer Service And Sales Division, manufactures and services advanced analytical laboratory instrumentation—gas chromatography-mass spectrometry systems, liquid chromatography-mass spectrometry equipment, inductively coupled plasma spectrometers, and specialized consumables—as a prime contractor across full-and-open federal procurement with no SBA certifications. The division operates as a child entity of Agilent Technologies, Inc., a Delaware-incorporated for-profit manufacturer headquartered in Santa Clara, California, competing exclusively without set-asides across a highly fragmented customer base of 236 federal agencies.

Agilent's federal footprint is dominated by equipment sales and maintenance services. Representative recent prime awards include a $10.8 million Transportation Security Administration definitive contract (September 2026) for procurement and delivery of up to 174 Bulk Resolution Technology systems with installation and two-year maintenance, a $10.7 million CDC Pittsburgh delivery order (April 2026) for five-year maintenance and repair of gas chromatography-mass spectrometry and related analytical instruments under the GSA Multiple Award Schedule, a $1.3 million U.S. Geological Survey definitive contract (September 2026) for four-year maintenance and software support of six liquid chromatography triple quadrupole mass spectrometers at the National Water Quality Laboratory in Lakewood, Colorado, and a $2.6 million Army Research Development and Engineering Command delivery order (September 2026) for yearly full-service preventative maintenance, unlimited on-site repairs, software upgrades, and technical support through March 2031. The division also holds a $14.3 million single-award indefinite delivery contract with the Army Research Development and Engineering Command for preventative maintenance and repair services through January 2030 and a $9.6 million Blanket Purchase Agreement with the Food and Drug Administration (August 2026, expiring May 2031) for HPLC/UHPLC and GC-MS systems with installation and training.

Customer concentration is moderate and split between volume and dollars. The top five funding agencies by award count—the Drug Enforcement Administration (520 awards, $42.4 million), FDA (434 awards, $81 million), National Cancer Institute (295 awards, $7.6 million), CDC Pittsburgh (256 awards, $56.3 million), and Agricultural Research Service (228 awards, $9.2 million)—account for 25% of awards but anchor the portfolio. By potential value, FDA leads at $81 million across 434 awards, followed by the Navy Bureau of Medicine and Surgery ($71.1 million, 97 awards), Army Materiel Command Research Development and Engineering Command ($63.7 million, 138 awards), and CDC Pittsburgh ($56.3 million, 256 awards). The FDA and Navy are anchors on dollars; the DEA drives volume through high-transaction, lower-value service and consumables orders.

Agilent operates predominantly through the GSA Multiple Award Schedule, holding 2,632 task orders valued at $347.2 million combined—roughly 40% of the vendor's recent federal potential-value footprint. Federal Supply Schedules GS00F5944A and GS26F5944AN615 account for 184 and 126 task orders respectively. The company also holds two Army indefinite delivery contracts—W91ZLK14D0005 (26 task orders, $5.8 million) and W91ZLK19D0006 (25 task orders, $11.9 million)—representing standing agreements for analytical equipment maintenance and repair across military laboratory operations.

Award activity has declined modestly year over year: 359 awards in FY2022, 377 in FY2023, 370 in FY2024, 307 in FY2025, and 244 in 2026 (through December 3). This trajectory reflects both market saturation in commodity analytical instrumentation and federal budget constraints on research and laboratory operations. Agilent faces a recompete cliff of 243 awards valued at $42.2 million combined completing inside the next twenty-four months, representing roughly 5% of the current potential-value footprint but constituting material renewal exposure across NASA, EPA, NIH, CDC, and DoD customers.

Agilent operates as a prime contractor on 99% of its awards; sub-awards comprise only 1% and are concentrated under defense prime contractors including KBR Wyle Services, LLC (for laboratory instrumentation and consumables under HHPC2), Pantexas Deterrence LLC (for repairs and support services at the Pantex Plant), and Hanford Laboratory Management And Integration LLC (for GC-MS software upgrades). The company delivers primarily through its own technical workforce; SCI-reportable invoicing totaled $3.4 million across FY2022–FY2025 (FY2024: $2.6 million, FY2025: $848 thousand), with median government-paid hourly rates around $2,368/hr and senior labor pricing reaching $4,724/hr on prime service contracts. Sub-hours share across SCI-reportable prime contracts averaged 0%, indicating Agilent builds its own delivery teams rather than relying on subcontractors for federal service work.

The company's federal portfolio is heavily concentrated in analytical laboratory instrument manufacturing (4,604 awards) and equipment repair and maintenance (826 awards), with Laboratory Equipment And Supplies (PSC code, 2,486 awards) and Maint/Repair/Rebuild Of Equipment instruments (1,963 awards) dominating procurement activity. This reflects Agilent's market position as the original equipment manufacturer for sophisticated mass spectrometry and chromatography systems used across federal research, law enforcement, and health agencies, combined with its recurring revenue model of sustaining installed bases through CrossLab maintenance service contracts and consumables replenishment. Sole-source and limited-competition awards recur across the portfolio, justified by OEM designation, proprietary parts and software, and certification requirements that restrict repair to factory-authorized service providers.